Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2017
At a glance
- Drugs Armodafinil (Primary)
- Indications Fatigue; Insomnia
- Focus Therapeutic Use
- 01 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Nov 2014 Planned End Date changed from 1 May 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.